Literature DB >> 2003535

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor.

G C Rodriguez1, A Berchuck, R S Whitaker, D Schlossman, D L Clarke-Pearson, R C Bast.   

Abstract

Previously we have shown that epidermal growth factor acts as a mitogen for some, but not all, ovarian cancer cells in culture. In this study we examined the effect of epidermal growth factor on proliferation of normal human ovarian epithelial cells in monolayer culture. We found that epidermal growth factor stimulated twofold to fourfold increases in proliferation in epithelial cells from each of five normal ovaries (p less than 0.01). In addition, Scatchard analysis of binding of epidermal growth factor tagged with iodine 125 indicated the presence of high-affinity receptors in all of the ovarian epithelial cells and ovarian cancer cell lines. The number and affinity of receptors was similar in the normal epithelium and cancer cell lines, and there was no relationship between epidermal growth factor receptor number and responsiveness to epidermal growth factor. We conclude that human ovarian epithelial cells normally express epidermal growth factor receptors and that epidermal growth factor acts as a mitogen for these cells. Although the mitogenic response to epidermal growth factor often is attenuated in ovarian cancer cell lines, loss of responsiveness to epidermal growth factor does not appear to be due to decreased receptor expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003535     DOI: 10.1016/0002-9378(91)90508-o

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells.

Authors:  S Misiti; S Nanni; G Fontemaggi; Y S Cong; J Wen; H W Hirte; G Piaggio; A Sacchi; A Pontecorvi; S Bacchetti; A Farsetti
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 2.  EGFR/HER-targeted therapeutics in ovarian cancer.

Authors:  Jason A Wilken; Tayf Badri; Sarah Cross; Rhoda Raji; Alessandro D Santin; Peter Schwartz; Adam J Branscum; Andre T Baron; Adam I Sakhitab; Nita J Maihle
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

3.  Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines.

Authors:  V J Möbus; W Asphal; P G Knapstein; R Kreienberg
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

Authors:  T Yano; J Pinski; G Halmos; K Szepeshazi; K Groot; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

5.  Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.

Authors:  D P Wang; I Konishi; M Koshiyama; Y Nanbu; T Iwai; H Nonogaki; T Mori; S Fujii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Absence of constitutive EGF receptor activation in ovarian cancer cell lines.

Authors:  C Ottensmeier; L Swanson; T Strobel; B Druker; J Niloff; S A Cannistra
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

7.  Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.

Authors:  S C Henzen-Logmans; E M Berns; J G Klijn; M E van der Burg; J A Foekens
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

8.  The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.

Authors:  J M Bartlett; S P Langdon; B J Simpson; M Stewart; D Katsaros; P Sismondi; S Love; W N Scott; A R Williams; A M Lessells; K G Macleod; J F Smyth; W R Miller
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

9.  In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.

Authors:  D R Negri; E Tosi; O Valota; S Ferrini; A Cambiaggi; S Sforzini; A Silvani; P A Ruffini; M I Colnaghi; S Canevari
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

Review 10.  Animal models of ovarian cancer.

Authors:  Barbara C Vanderhyden; Tanya J Shaw; Jean-François Ethier
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.